Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ophthalmology

Free Subscription Articles published in Surv Ophthalmol Retrieve available abstracts of 192 articles: HTML format

Single Articles

November 2025
1. BHATTI MT, Moore JG, Hwang TN, Bilyk JR, et al
   Blow.
   Surv Ophthalmol. 2025;70:1261-1266.
   PubMed     Abstract available
   
   
   
2. COUTURIER A, Wykoff CC, Lupidi M, Udaondo P, et al
   Anatomic biomarkers as potential endpoints in diabetic macular edema: A systematic literature review with identification of macular volume as a key surrogate for visual acuity.
   Surv Ophthalmol. 2025;70:1090-1110.
   PubMed     Abstract available
   
   
   
3. ZHANG P, Xu Z
   The advancements in precision medicine for Leber congenital amaurosis: Breakthroughs from genetic diagnosis to therapy.
   Surv Ophthalmol. 2025;70:1205-1219.
   PubMed     Abstract available
   
   
   
4. LEE SH, Ho YR, Li H, Tu YK, et al
   Prevalence and clinical manifestations of cytomegalovirus infection in patients with Posner-Schlossman syndrome: A systematic review and meta-analysis.
   Surv Ophthalmol. 2025;70:1252-1260.
   PubMed     Abstract available
   
   
   October 2025
5. NUSAIR O, Soleimani M
   Additional observations on ROCK inhibitors: Reticular corneal epithelial edema.
   Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00187.
   PubMed    
   
   
   
6. PARIS JE, Macri CZ, Lee YM, Chan WO, et al
   Retinal imaging options for differentiating degenerative retinoschisis from retinal detachment: A scoping review.
   Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00145.
   PubMed     Abstract available
   
   
   
7. HENEIN C, Tan JK, Steel DH, Ahmad S, et al
   Response to "Additional observations on ROCK inhibitors: reticular corneal epithelial edema".
   Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00186.
   PubMed    
   
   
   
8. LIU Y, Gong D, Dang K, Guo J, et al
   Diagnostic accuracy of next generation sequencing--based genetic research for primary glaucoma: A systematic review and meta-analysis.
   Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00181.
   PubMed     Abstract available
   
   
   
9. TAO BK, Hwang J, Park S, Mikhail D, et al
   Prefilled syringes and post-intravitreal injection endophthalmitis: A network meta-analysis.
   Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00184.
   PubMed     Abstract available
   
   
   
10. GHALIBAFAN S, Herskowitz WR, Chou BG, Rohowetz LJ, et al
    Isolated tattoo-associated uveitis without systemic sarcoidosis: A systematic review of case reports.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00183.
    PubMed     Abstract available
    
    
    
11. MERLE DA, Beretta F, Sacconi R, Querques G, et al
    Fibrogliosis in neovascular age-related macular degeneration: A new mechanistic perspective.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00185.
    PubMed     Abstract available
    
    
    
12. FEIZI S, Hatami F, Mirzaei SK, Bayat K, et al
    Medical and surgical approaches to prevent corneal graft rejection in high-risk recipients.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00182.
    PubMed     Abstract available
    
    
    September 2025
13. ESHRAGHI B, Babaei L, Aghajani A
    Altered ocular surface microbiome in nasolacrimal duct obstruction: Clinical Implications for intraocular surgery.
    Surv Ophthalmol. 2025 Sep 22:S0039-6257(25)00178.
    PubMed     Abstract available
    
    
    
14. TSENG YH, Wu PL, Kang EY, Chen KJ, et al
    Advancements in ocular blood flow imaging: Clinical applications of laser speckle flowgraphy and optical coherence tomography angiography in retinal and choroidal vascular diseases.
    Surv Ophthalmol. 2025 Sep 21:S0039-6257(25)00180.
    PubMed     Abstract available
    
    
    
15. SABOYA-GALINDO P, Cifuentes-Gonzalez C, Rojas-Carabali W, Mejia-Salgado G, et al
    Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A Systematic Review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) - Report 4.
    Surv Ophthalmol. 2025 Sep 20:S0039-6257(25)00173.
    PubMed     Abstract available
    
    
    
16. LEE E, Hunt D, Cakir Y, Kuo D, et al
    Artificial intelligence in age-related macular degeneration: Advancing diagnosis, prognosis, and treatment.
    Surv Ophthalmol. 2025 Sep 18:S0039-6257(25)00174.
    PubMed     Abstract available
    
    
    
17. SUGANYA DEVI K, Vasireddi HK, Reddy GR, Satti SK, et al
    Unfolding the diagnostic pipeline of diabetic retinopathy with artificial intelligence: A systematic review.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00170.
    PubMed     Abstract available
    
    
    
18. CIFUENTES-GONZALEZ CG, Putera I, Walter CFY, Mejia-Salgado MS, et al
    Work-up in patients with retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 2.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00175.
    PubMed     Abstract available
    
    
    
19. LA ROSA A, Feo A, Bousquet E, Cabral D, et al
    Angioid streaks-related choroidal neovascularization: Clinical features, multimodal imaging-based differential diagnosis, and optimized treatment strategies.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00169.
    PubMed     Abstract available
    
    
    
20. NANJI K, Hatamnejad A, Grad J, El-Sayes A, et al
    Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00176.
    PubMed     Abstract available
    
    
    
21. KOCAK I, Sayin N, Bayramoglu SE, Thalib L, et al
    Effect of methotrexate in preventing retinal detachment after proliferative vitreoretinopathy surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Sep 16:S0039-6257(25)00177.
    PubMed     Abstract available
    
    
    
22. SUMODHEE D, Ioannidou E, Ramessur R, Prashar J, et al
    Interventions to improve patients' knowledge in ophthalmology: A systematic review and narrative synthesis.
    Surv Ophthalmol. 2025 Sep 13:S0039-6257(25)00168.
    PubMed     Abstract available
    
    
    
23. LOH NC, Rojas-Carabali W, Lim YH, Bong JE, et al
    Choroidal Vascularity Index as a marker of health and disease: Systematic review and meta-Analyses.
    Surv Ophthalmol. 2025 Sep 5:S0039-6257(25)00164.
    PubMed     Abstract available
    
    
    
24. HATAMNEJAD A, Nanji K, Grad J, El-Sayes A, et al
    Predicting Treatment Response in Retinal Vein Occlusions Using Baseline Optical Coherence Tomography Biomarkers: A Systematic Review.
    Surv Ophthalmol. 2025 Sep 4:S0039-6257(25)00148.
    PubMed     Abstract available
    
    
    
25. SONG W, Chen W, Chi J, Liu X, et al
    The role of lipid metabolism disorder in the progression and treatment of ocular vascular diseases.
    Surv Ophthalmol. 2025 Sep 4:S0039-6257(25)00163.
    PubMed     Abstract available
    
    
    
26. LIU C, Yan R, Jiang J
    Adjustable suture versus nonadjustable suture surgery for childhood strabismus: A meta-analysis.
    Surv Ophthalmol. 2025;70:859-867.
    PubMed     Abstract available
    
    
    
27. CARLA MM, Ripa M, Crincoli E, Catania F, et al
    The spectrum of microcystic macular edema: Pathogenetic insights, clinical entities, and functional prognosis.
    Surv Ophthalmol. 2025;70:982-994.
    PubMed     Abstract available
    
    
    
28. JEAN-CHARLES S, Shoji MK, Kikkawa DO, Bhatti MT, et al
    The mirrored arterial dilemma.
    Surv Ophthalmol. 2025;70:1029-1033.
    PubMed     Abstract available
    
    
    August 2025
29. GIANNOPOULOS NG, Macri CZ, Seneviratne IAK, Bacchi S, et al
    A narrative review of the psychological impact of intravitreal injections.
    Surv Ophthalmol. 2025 Aug 28:S0039-6257(25)00144.
    PubMed     Abstract available
    
    
    
30. MOZAFAR M, Fekrazad S, Amanollahi M, Samiee R, et al
    Optical coherence tomography angiography measurements in thyroid eye disease: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Aug 20:S0039-6257(25)00143.
    PubMed     Abstract available
    
    
    
31. MALOOF AG, Zhang S, Pavic NV, Coroneo MT, et al
    'Seeing both sides': A systematic review of the Miyake-Apple video system's role in Ophthalmology.
    Surv Ophthalmol. 2025 Aug 20:S0039-6257(25)00134.
    PubMed     Abstract available
    
    
    
32. QIAN Y, Lin X, Wang Y, Mao Y, et al
    In vivo detection of macrophage-like cells at the vitreoretinal interface in retinal diseases using optical coherence tomography angiography.
    Surv Ophthalmol. 2025 Aug 19:S0039-6257(25)00141.
    PubMed     Abstract available
    
    
    
33. LE NVA, Nguyen NC, Kasetsuwan N, Reinprayoon U, et al
    Corrigendum to "Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis" [Survey Ophthalomol., vol. 70 (2025) P480-488/ PMID: 39709033].
    Surv Ophthalmol. 2025 Aug 18:S0039-6257(25)00137.
    PubMed    
    
    
    
34. SEN M, Munier FL, Honavar SG
    Intraocular seeds in retinoblastoma: A review of classification, management, and outcomes.
    Surv Ophthalmol. 2025 Aug 15:S0039-6257(25)00139.
    PubMed     Abstract available
    
    
    
35. RAJESWAREN V, Trivedi V, Yoganathan P
    Macular hole after anti-Vascular Endothelial Growth factor injection: A review.
    Surv Ophthalmol. 2025 Aug 14:S0039-6257(25)00140.
    PubMed     Abstract available
    
    
    
36. PARIS JE, Macri CZ, Lake SR, Chan WO, et al
    Risk factors for retinal breaks following surgical induction of posterior vitreous detachment: A scoping review.
    Surv Ophthalmol. 2025 Aug 12:S0039-6257(25)00138.
    PubMed     Abstract available
    
    
    
37. DIRANI K, Kim C, Park J, Gregory A, et al
    Clinical Implications of heavy silicon oil (Densiron(R)) endotamponade after pars plana vitrectomy: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Aug 7:S0039-6257(25)00132.
    PubMed     Abstract available
    
    
    
38. GAO J, Wang W, Mo Y
    Retinal Degenerative Diseases: Complement system-Microglia Crosstalk.
    Surv Ophthalmol. 2025 Aug 5:S0039-6257(25)00135.
    PubMed     Abstract available
    
    
    July 2025
39. HE M, Yang Z, Shi Z, Chen Y, et al
    Clinical features, management, and prognosis factors of traumatic optic neuropathy.
    Surv Ophthalmol. 2025 Jul 30:S0039-6257(25)00129.
    PubMed     Abstract available
    
    
    
40. CARLA MM, Mottola F, Cusato M, Oreste G, et al
    Vitreoretinal interface abnormalities in age-related macular degeneration: Prevalence, pathophysiology, and reciprocal influence.
    Surv Ophthalmol. 2025 Jul 23:S0039-6257(25)00126.
    PubMed     Abstract available
    
    
    
41. DRAKOPOULOS M, Nadel A, Bains HK, Bisen JB, et al
    Quantitative ophthalmic posterior segment optical coherence tomography angiography and systemic conditions.
    Surv Ophthalmol. 2025 Jul 21:S0039-6257(25)00123.
    PubMed     Abstract available
    
    
    
42. ZHANG HY, Smith AW, Laferriere HE, Finn AP, et al
    The use of time-driven activity-based costing in ophthalmology: A scoping review.
    Surv Ophthalmol. 2025 Jul 19:S0039-6257(25)00122.
    PubMed     Abstract available
    
    
    
43. JIN K, Yu T, Grzybowski A
    Multimodal artificial intelligence in ophthalmology: Applications, challenges, and future directions.
    Surv Ophthalmol. 2025 Jul 17:S0039-6257(25)00120.
    PubMed     Abstract available
    
    
    
44. SUH A, Szeto JJ, Ong J, Armstrong GW, et al
    Ocular trauma in microgravity: In-flight diagnostics and extraterrestrial strategies for management.
    Surv Ophthalmol. 2025 Jul 15:S0039-6257(25)00124.
    PubMed     Abstract available
    
    
    
45. CARLA MM, Couturier A, Mottola F, Cusato M, et al
    The influence of scleral buckle on choroidal architecture: An unexplored link with the spectrum of acquired overload choroidopathy?
    Surv Ophthalmol. 2025 Jul 9:S0039-6257(25)00108.
    PubMed     Abstract available
    
    
    
46. WAN Y, Guo X, Wang N
    Trabecular meshwork: A pivotal target for evolving glaucoma treatments.
    Surv Ophthalmol. 2025 Jul 8:S0039-6257(25)00107.
    PubMed     Abstract available
    
    
    
47. VILARES-MORGADO R, Verbruggen K, Stalmans I, Barbosa-Breda J, et al
    Age-related changes in optical coherence tomography glaucoma-related parameters: A systematic review.
    Surv Ophthalmol. 2025 Jul 3:S0039-6257(25)00104.
    PubMed     Abstract available
    
    
    
48. KHOSRAVI MIRZAEI S, Hatami F, Safi S, Khorrami Z, et al
    Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2025;70:633-644.
    PubMed     Abstract available
    
    
    
49. JAIN M, Mohankumar A, Torres J, Alkorbi HA, et al
    Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids.
    Surv Ophthalmol. 2025;70:616-632.
    PubMed     Abstract available
    
    
    
50. ARRUDA MP, Hira S, Lima RV, Barbosa LIT, et al
    Pharmacological therapy for relieving pain in panretinal photocoagulation: A network meta-analysis of randomized controlled trials.
    Surv Ophthalmol. 2025;70:645-652.
    PubMed     Abstract available
    
    
    
51. SHETH JU, Stewart MW, Narayanan R, Anantharaman G, et al
    Macular neovascularization.
    Surv Ophthalmol. 2025;70:653-675.
    PubMed     Abstract available
    
    
    
52. WOUDSTRA-DE JONG JE, Busschbach JJ, Manning-Charalampidou SS, Vingerling JR, et al
    Assessment of patient-reported outcomes in vitreomacular interface disorders: A systematic literature review.
    Surv Ophthalmol. 2025;70:685-694.
    PubMed     Abstract available
    
    
    
53. MELENDEZ-MORENO A, Yesiltas YS, Jacquelyn Wrenn NP, Singh AD, et al
    Corrigendum to "Iris melanoma: Prognostication for metastasis"[Survey Ophthalmol 68 (2023) 957-963].
    Surv Ophthalmol. 2025 Jul 1:S0039-6257(25)00106.
    PubMed    
    
    
    June 2025
54. SONG A, Lee E, Ostmo SR, Jonas KE, et al
    Retinopathy of prematurity training and education: A systematic review.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00102.
    PubMed     Abstract available
    
    
    
55. VON DER EMDE L, Petzinna SM, Herwig-Carl MC, Adamson MS, et al
    Advances in diagnosing and treating giant cell arteritis: New hope for arteritic anterior ischemic optic neuropathy.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00103.
    PubMed     Abstract available
    
    
    
56. YANG WYL, Wong HJ, Fu CE, Rojas-Carabali W, et al
    Artificial intelligence in the prediction of glaucoma development and progression: A systematic review.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00105.
    PubMed     Abstract available
    
    
    
57. HAMMOUD B, Schumacher JS, Zhang H, Dutra BAL, et al
    Brillouin microscopy for focal biomechanical measurements in normal and keratoconic corneas: A narrative review.
    Surv Ophthalmol. 2025 Jun 11:S0039-6257(25)00099.
    PubMed     Abstract available
    
    
    
58. TOVEY CRUTCHFIELD EC, Vincent AL, Anjou MD, Taylor HR, et al
    Inherited retinal disease in global Indigenous populations: A scoping review.
    Surv Ophthalmol. 2025 Jun 11:S0039-6257(25)00101.
    PubMed     Abstract available
    
    
    
59. WOO J, Chopra S, Liu K, Tuttle B, et al
    Impact of neighborhood-level deprivation on glaucoma prevalence and treatment: A review of the literature.
    Surv Ophthalmol. 2025 Jun 10:S0039-6257(25)00100.
    PubMed     Abstract available
    
    
    
60. HAN L, Mao Y, Sang Q, Wan Y, et al
    Efficacy and complications of microcatheter-assisted minimally invasive glaucoma surgery for open-angle glaucoma: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2025 Jun 6:S0039-6257(25)00097.
    PubMed     Abstract available
    
    
    May 2025
61. ALKHABAZ A, Pujari R, Ren Y, Smith SJ, et al
    Optic disc drusen-associated neovascularization: A systematic review.
    Surv Ophthalmol. 2025 May 27:S0039-6257(25)00095.
    PubMed     Abstract available
    
    
    
62. CHEN KY, Chan HC, Chan CM
    Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: A systematic review and network meta-analysis of randomized controlled trials.
    Surv Ophthalmol. 2025 May 24:S0039-6257(25)00096.
    PubMed     Abstract available
    
    
    
63. KHAN MMH, Akhlaq A, Khan MJ, Ali M, et al
    Impact of social determinants of health on causes of ophthalmic trauma: A narrative review.
    Surv Ophthalmol. 2025 May 24:S0039-6257(25)00091.
    PubMed     Abstract available
    
    
    
64. RAHMANIPOUR E, Sadeghi E, Arora S, Ghorbani M, et al
    Choroidal hypopigmented lesions: A review.
    Surv Ophthalmol. 2025 May 14:S0039-6257(25)00073.
    PubMed     Abstract available
    
    
    
65. SINGH SR, Sadeghi E, Vupparaboina KK, Chhablani J, et al
    Recent updates in choroidal imaging biomarkers.
    Surv Ophthalmol. 2025 May 13:S0039-6257(25)00075.
    PubMed     Abstract available
    
    
    
66. ERDAG M, Citirik M, Dal A
    Augmented and virtual reality in retinal care: A systematic review of their role in training, surgery, and treatment.
    Surv Ophthalmol. 2025 May 10:S0039-6257(25)00072.
    PubMed     Abstract available
    
    
    
67. CHRONOPOULOS A, Schutz JS, Finger RP
    Prevention of rhegmatogenous retinal detachment.
    Surv Ophthalmol. 2025 May 6:S0039-6257(25)00071.
    PubMed     Abstract available
    
    
    
68. CIFUENTES-GONZALEZ C, Le Tong Y, Rojas-Carabali W, Mejia-Salgado G, et al
    Systematic Review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3.
    Surv Ophthalmol. 2025 May 2:S0039-6257(25)00066.
    PubMed     Abstract available
    
    
    
69. SADEGHI E, Colorado-Zavala MF, Almuhtaseb H, Venkatesh R, et al
    Anatomical and functional changes after internal limiting membrane peeling.
    Surv Ophthalmol. 2025;70:357-368.
    PubMed     Abstract available
    
    
    
70. CHOPRA P, Fatima A, Mohapatra S, Murugaiyan K, et al
    Extracellular vesicles in dry eye disease and Sjogren's syndrome: A systematic review on their diagnostic and therapeutic role.
    Surv Ophthalmol. 2025;70:499-515.
    PubMed     Abstract available
    
    
    April 2025
71. TAN JK, Steel DH, Ahmad S, Viswanathan A, et al
    Exploring the potential of Rho kinase inhibitors in ophthalmology: From mechanisms to clinical practice.
    Surv Ophthalmol. 2025 Apr 16:S0039-6257(25)00058.
    PubMed     Abstract available
    
    
    
72. GRASSMEYER JJ, Pennesi ME, Yang P, Tschetter W, et al
    Effects of medications on the human electroretinogram: A comprehensive review.
    Surv Ophthalmol. 2025 Apr 12:S0039-6257(25)00067.
    PubMed     Abstract available
    
    
    
73. UCAR F
    Comment on: "Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis".
    Surv Ophthalmol. 2025 Apr 3:S0039-6257(25)00065.
    PubMed    
    
    
    March 2025
74. MASTROGIUSEPPE E, Alisi L, Romaniello A, Caterino L, et al
    Managing Cutibacterium acnes endophthalmitis after cataract surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Mar 29:S0039-6257(25)00061.
    PubMed     Abstract available
    
    
    
75. AGARWAL A, Vempuluru VS, Kaliki S
    Primary Ocular, Adnexal, and Orbital Rhabdomyosarcoma: A Review.
    Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00060.
    PubMed     Abstract available
    
    
    
76. HUNG JH, Jain T, Khatri A, Nguyen TB, et al
    Inherited retinal diseases-associated uveitis.
    Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00057.
    PubMed     Abstract available
    
    
    
77. SHAIKH N, Kumawat D, Chandra P, Senthil S, et al
    Glaucoma in retinopathy of prematurity - A review.
    Surv Ophthalmol. 2025 Mar 25:S0039-6257(25)00056.
    PubMed     Abstract available
    
    
    
78. SIT AJ, Aihara M, Khawaja AP, Lin SC, et al
    Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors.
    Surv Ophthalmol. 2025 Mar 17:S0039-6257(25)00052.
    PubMed     Abstract available
    
    
    
79. GHALEB R, Sallam AB, Grigorian F, Phillips PH, et al
    Oral fluorescein angiography in pediatric ophthalmology.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00051.
    PubMed     Abstract available
    
    
    
80. CHEN Y, Jiang F, Zeng Y, Zhang M, et al
    The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00053.
    PubMed     Abstract available
    
    
    
81. YAO A, Hussain A, Kannan R, Nduka C, et al
    Dynamic procedures for eyelid involvement in facial nerve palsy.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00054.
    PubMed     Abstract available
    
    
    
82. RODRIGUEZ-GARCIA A, Ruiz-Lozano RE, Barcelo-Canton RH, Marines-Sanchez HM, et al
    The Etiologic and Pathogenic Spectrum of Exposure Keratopathy: Diagnostic and Therapeutic Implications.
    Surv Ophthalmol. 2025 Mar 8:S0039-6257(25)00050.
    PubMed     Abstract available
    
    
    
83. RICKELS KL, Ghaleb R, Elhusseiny AM, Chauhan MZ, et al
    Ocular manifestations secondary to cocaine abuse.
    Surv Ophthalmol. 2025 Mar 5:S0039-6257(25)00032.
    PubMed     Abstract available
    
    
    
84. NEFFENDORF JE, Jackson TL
    Presumed phototoxicity from macular vital staining with Brilliant Blue G and Trypan Blue: A post-market surveillance study, systematic review, and synthesis of the literature.
    Surv Ophthalmol. 2025;70:339-351.
    PubMed     Abstract available
    
    
    
85. LEI Y, Wang Y, Tang S, Yang J, et al
    The adaptive immune system in the retina of diabetics.
    Surv Ophthalmol. 2025;70:241-254.
    PubMed     Abstract available
    
    
    
86. BHATTI MT, Fors DH, Muminovic I, Robbins SL, et al
    Heavy duty.
    Surv Ophthalmol. 2025;70:352-355.
    PubMed     Abstract available
    
    
    
87. ZHANG Q, Wang S, Wang X, Xu C, et al
    Advancing Ophthalmology With Large Language Models: Applications, Challenges, and Future Directions.
    Surv Ophthalmol. 2025 Mar 1:S0039-6257(25)00037.
    PubMed     Abstract available
    
    
    February 2025
88. DUNNIGAN JK, Wang CY, George L, Lee VA, et al
    Social Media in Ophthalmology: A Comprehensive Literature Review.
    Surv Ophthalmol. 2025 Feb 22:S0039-6257(25)00031.
    PubMed     Abstract available
    
    
    
89. GHAFARIAN S, Samavat B, Lee K, Sheikhghomi S, et al
    Clinical strategies to prevent recurrence of Herpes simplex and Herpes zoster following ocular surgery: A comprehensive review with practical guidelines.
    Surv Ophthalmol. 2025 Feb 15:S0039-6257(25)00029.
    PubMed     Abstract available
    
    
    
90. AL-DABET S, Turaev S, Zaki N
    Ocular-Induced Abnormal Head Postures: A Systematic Review and Analysis.
    Surv Ophthalmol. 2025 Feb 9:S0039-6257(25)00021.
    PubMed     Abstract available
    
    
    
91. ZHANG C, Lai D, Zhu D, Palka C, et al
    Chlorhexidine for ocular antisepsis before intravitreal injection: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Feb 6:S0039-6257(25)00024.
    PubMed     Abstract available
    
    
    
92. CIFUENTES-GONZALEZ C, Le Tong Y, Mejia-Salgado G, Chan R, et al
    Global demographic and etiological variations of retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1.
    Surv Ophthalmol. 2025 Feb 5:S0039-6257(25)00023.
    PubMed     Abstract available
    
    
    January 2025
93. YANG Z, Tian D, Xie Z, Cheng T, et al
    Clinical features, diagnosis, management, and prognosis of circumscribed choroidal hemangioma.
    Surv Ophthalmol. 2025 Jan 23:S0039-6257(25)00011.
    PubMed     Abstract available
    
    
    
94. SADEGHI E, Rahmanipour E, Valsecchi N, Kapoor S, et al
    An update on ocular effects of antidiabetic medications.
    Surv Ophthalmol. 2025 Jan 22:S0039-6257(25)00019.
    PubMed     Abstract available
    
    
    
95. TURCAS C, Nicoara SD
    A comprehensive review of structure-function correlations in age-related macular degeneration: Contributions of microperimetry.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00017.
    PubMed     Abstract available
    
    
    
96. ORTIZ-MORALES G, Ruiz-Lozano RE, Morales-Mancillas N, Homar Paez-Garza J, et al
    Pediatric blepharokeratoconjunctivitis: A challenging ocular surface disease.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00009.
    PubMed     Abstract available
    
    
    
97. BAYAT K, Pooyan P, Looha MA, Namakin K, et al
    Retinal structural alterations in patients with epilepsy taking antiepileptic drugs: A systematic review and meta-analysis of OCT findings.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00012.
    PubMed     Abstract available
    
    
    
98. FORTE P, Paques M, Cattaneo J, Dupas B, et al
    Perifoveal vascular anomalous complex and telangiectatic capillaries: An overview of two entities potentially sharing a common pathophysiology.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00014.
    PubMed     Abstract available
    
    
    
99. FEO A, Stradiotto E, Govetto A, Forte P, et al
    Bacillary layer detachment: Updates on its clinical and prognostic significance in retinal disease.
    Surv Ophthalmol. 2025 Jan 14:S0039-6257(25)00013.
    PubMed     Abstract available
    
    
    
100. DE LOTT LB, Kaplan C, Harte S, Clauw DJ, et al
     Nociplastic pain among individuals with chronic ocular surface pain: one cause for "pain without stain"?
     Surv Ophthalmol. 2025 Jan 13:S0039-6257(25)00015.
     PubMed     Abstract available
     
     
     
101. LIU T, Elnahry AG, Tauqeer Z, Yu Y, et al
     Incidence and risk factors of perioperative suprachoroidal hemorrhage: A systematic review and meta-analysis.
     Surv Ophthalmol. 2025;70:54-62.
     PubMed     Abstract available
     
     
     
102. YANG W, Ren R, Xie Y, Wang J, et al
     Diabetic uveopathy.
     Surv Ophthalmol. 2025;70:47-53.
     PubMed     Abstract available
     
     
     
103. BHATTI MT, Long JR, Carey AR
     Denial.
     Surv Ophthalmol. 2025;70:162-166.
     PubMed     Abstract available
     
     
     December 2024
104. LIN TH, Lin HY, Tseng PC
     Enhancing anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy: A meta-analysis.
     Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00157.
     PubMed     Abstract available
     
     
     
105. NGOC VAN ANH L, Ngoc Cong N, Ngamjit K, Usanee R, et al
     Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis.
     Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00156.
     PubMed     Abstract available
     
     
     
106. SERVILLO A, Scandale P, Oldoni G, Begar PG, et al
     Inflammatory choroidal neovascularization: An evidence-based update.
     Surv Ophthalmol. 2024 Dec 18:S0039-6257(24)00155.
     PubMed     Abstract available
     
     
     
107. JIRAVARNSIRIKUL A, Belghith A, Rezapour J, Bowd C, et al
     Evaluating glaucoma in myopic eyes: Challenges and opportunities.
     Surv Ophthalmol. 2024 Dec 17:S0039-6257(24)00154.
     PubMed     Abstract available
     
     
     
108. SANTINA A, Feo A, Bousquet E, Velaga SB, et al
     Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease.
     Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00153.
     PubMed     Abstract available
     
     
     
109. NAGINO K, Inomata T, Ohta T, Sung J, et al
     Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00152.
     PubMed     Abstract available
     
     
     November 2024
110. EIJGEN JV, Winckel LV, Hanssen H, Kotliar K, et al
     Retinal vessel analysis to assess microvascular function in the healthy eye: A systematic review on the response to acute physiological and pathological stressors.
     Surv Ophthalmol. 2024 Nov 24:S0039-6257(24)00140.
     PubMed     Abstract available
     
     
     
111. RAI BB, Maddess T, Nolan CJ
     Functional diabetic retinopathy: A new concept to improve management of diabetic retinal diseases.
     Surv Ophthalmol. 2024 Nov 23:S0039-6257(24)00142.
     PubMed     Abstract available
     
     
     
112. ISSA M, Sukkarieh G, Gallardo M, Sarbout I, et al
     Applications of artificial intelligence to inherited retinal diseases: A systematic review.
     Surv Ophthalmol. 2024 Nov 18:S0039-6257(24)00139.
     PubMed     Abstract available
     
     
     
113. LEE SJV, FRCOphth, Goh YQ, Rojas-Carabali W, et al
     Association between retinal vessels caliber and systemic health: A comprehensive review.
     Surv Ophthalmol. 2024 Nov 16:S0039-6257(24)00138.
     PubMed     Abstract available
     
     
     
114. VAHEB S, Panah MY, Shaygannejad V, Zabeti A, et al
     Uveitis among people with multiple sclerosis: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Nov 15:S0039-6257(24)00134.
     PubMed     Abstract available
     
     
     
115. PUTERA I, Distia Nora R, Dewi AC, Suhada DS, et al
     Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Nov 14:S0039-6257(24)00141.
     PubMed     Abstract available
     
     
     
116. RIZZO C, Savastano MC, Kilian R, Marchini G, et al
     Structural en face optical coherence tomography in neovascular and nonneovascularage-related macular degeneration: Use and utility in clinical practice.
     Surv Ophthalmol. 2024 Nov 8:S0039-6257(24)00135.
     PubMed     Abstract available
     
     
     
117. LI L, Xiao K, Shang X, Hu W, et al
     Advances in artificial intelligence for meibomian gland evaluation: A comprehensive review.
     Surv Ophthalmol. 2024;69:945-956.
     PubMed     Abstract available
     
     
     October 2024
118. ELSAYED MEA, Lander B, Senthil S, Edward DP, et al
     The Secondary Childhood Glaucomas.
     Surv Ophthalmol. 2024 Oct 30:S0039-6257(24)00132.
     PubMed     Abstract available
     
     
     
119. SADEGHI E, Valsecchi N, Rahmanipour E, Ejlalidiz M, et al
     Choroidal biomarkers in age-related macular degeneration.
     Surv Ophthalmol. 2024 Oct 17:S0039-6257(24)00131.
     PubMed     Abstract available
     
     
     
120. ALBRECHT M, Auffarth GU, Friedrich M, Kessler LJ, et al
     Vision degrading myodesopsia from vitreous floaters in the young: An important aspect of myopia.
     Surv Ophthalmol. 2024 Oct 16:S0039-6257(24)00128.
     PubMed     Abstract available
     
     
     
121. NEWMAN NJ, Biousse V, Yu-Wai-Man P, Carelli V, et al
     Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy.
     Surv Ophthalmol. 2024 Oct 15:S0039-6257(24)00130.
     PubMed     Abstract available
     
     
     
122. GUPTA Y, Devi C, Priyadarshini K, Mandal S, et al
     Pediatric Keratoconus.
     Surv Ophthalmol. 2024 Oct 11:S0039-6257(24)00129.
     PubMed     Abstract available
     
     
     
123. HOVEN E, Michelet JT, Vettore MV, Lagali N, et al
     Choroidal thickness after anti-VEGF in typical neovascular age-related macular degeneration - A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Oct 5:S0039-6257(24)00124.
     PubMed     Abstract available
     
     
     September 2024
124. MIKHAIL D, Milad D, Antaki F, Hammamji K, et al
     The role of artificial intelligence in macular hole management: A scoping review.
     Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00123.
     PubMed     Abstract available
     
     
     
125. BERMAN G, Pendley AM, Wright DW, Silverman R, et al
     Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department.
     Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00127.
     PubMed     Abstract available
     
     
     
126. TAN JCK, Yohannan J, Ramulu PY, Kalloniatis M, et al
     Visual field testing in glaucoma using the Swedish Interactive Threshold Algorithm.
     Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00118.
     PubMed     Abstract available
     
     
     
127. STALHAMMAR G, Hagstrom A, Ermedahl Conradi M, Williams PA, et al
     Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00117.
     PubMed     Abstract available
     
     
     
128. ALISI L, Giovannetti F, Armentano M, Lucchino L, et al
     Challenging corneal diseases and miRNA expression: Focus on rare diseases and new therapeutic frontiers.
     Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00120.
     PubMed     Abstract available
     
     
     
129. FERRO DESIDERI L, Sim PY, Bernardi E, Paschon K, et al
     Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage.
     Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00119.
     PubMed     Abstract available
     
     
     
130. D'ALBENZIO A, Komici K, Affatato M, Castelluzzo AM, et al
     Vitreous Cortex Remnants in Patients With Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-analysis.
     Surv Ophthalmol. 2024 Sep 26:S0039-6257(24)00121.
     PubMed     Abstract available
     
     
     
131. LEI C, Lv Z, Hua R, Duan J, et al
     Focal choroidal excavation: Review and updated pathogenesis.
     Surv Ophthalmol. 2024 Sep 25:S0039-6257(24)00126.
     PubMed     Abstract available
     
     
     
132. YANG Q, Ju G, He Y
     Corneal densitometry: New evaluation indicator for corneal diseases.
     Surv Ophthalmol. 2024 Sep 24:S0039-6257(24)00122.
     PubMed     Abstract available
     
     
     
133. WANG K, Liu Y, Li S, Zhao N, et al
     Unveiling the therapeutic potential and mechanisms of stanniocalcin-1 in retinal degeneration.
     Surv Ophthalmol. 2024 Sep 11:S0039-6257(24)00085.
     PubMed     Abstract available
     
     
     
134. SUH A, Ditelberg S, Szeto JJ, Kumar D, et al
     Safety protocols, precautions, and countermeasures aboard the International Space Station (ISS) to prevent ocular injury.
     Surv Ophthalmol. 2024 Sep 3:S0039-6257(24)00097.
     PubMed     Abstract available
     
     
     
135. L'ABBATE D, Prescott K, Geraghty B, Kearns VR, et al
     Biomechanical considerations for optimising subretinal injections.
     Surv Ophthalmol. 2024;69:722-732.
     PubMed     Abstract available
     
     
     
136. TAWFIK HA, Ali MJ
     A major review on punctal stenosis: Part II: Updated therapeutic interventions, complications, and outcomes.
     Surv Ophthalmol. 2024;69:756-768.
     PubMed     Abstract available
     
     
     
137. BIRCH EE, Duffy KR
     Leveraging neural plasticity for the treatment of amblyopia.
     Surv Ophthalmol. 2024;69:818-832.
     PubMed     Abstract available
     
     
     
138. CHEN JS, Korn BS, Carey AR, Savino PJ, et al
     Looking beyond blurred margins.
     Surv Ophthalmol. 2024;69:842-846.
     PubMed     Abstract available
     
     
     August 2024
139. CHAUHAN K, Dave VP, de Ribot FM, Agrawal R, et al
     Traumatic retinal detachment: A contemporary update.
     Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00101.
     PubMed     Abstract available
     
     
     
140. MANO F, LoBue S, Tailor P, Olsen TW, et al
     Incisional choroidal surgery.
     Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00096.
     PubMed     Abstract available
     
     
     
141. JESSUP AJC, Coroneo MT
     Examining the fabric of the eye: Antoni van Leeuwenhoek, the draper and ocular microscopist.
     Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00098.
     PubMed     Abstract available
     
     
     
142. ZHAO Q, Wei L, Chen Y
     Detection of choroidal vascular features in diabetic patients without clinically visible diabetic retinopathy by optical coherence tomography angiography: A systemic review and meta-analysis.
     Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00100.
     PubMed     Abstract available
     
     
     
143. SURICO PL, Barone V, Singh RB, Coassin M, et al
     Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders.
     Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00083.
     PubMed     Abstract available
     
     
     
144. SCHLOESSER L, Klose SM, Mauschitz MM, Abdullah Z, et al
     The role of immune modulators in age-related macular degeneration.
     Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00084.
     PubMed     Abstract available
     
     
     July 2024
145. MARMOR MF
     Lupus review is misleading about risk of hydroxychloroquine retinal toxicity.
     Surv Ophthalmol. 2024 Jul 24:S0039-6257(24)00082.
     PubMed    
     
     
     
146. ZHANG Z, Shan X, Li S, Chang J, et al
     Retinal light damage: From mechanisms to protective strategies.
     Surv Ophthalmol. 2024 Jul 23:S0039-6257(24)00079.
     PubMed     Abstract available
     
     
     
147. VUJOSEVIC S, Lupidi M, Donati S, Astarita C, et al
     Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration.
     Surv Ophthalmol. 2024 Jul 17:S0039-6257(24)00080.
     PubMed     Abstract available
     
     
     
148. FOUAD YA, Cicinelli MV, Marchese A, Casalino G, et al
     Revisiting acute retinal pigment epitheliitis (Krill disease).
     Surv Ophthalmol. 2024 Jul 16:S0039-6257(24)00078.
     PubMed     Abstract available
     
     
     
149. TORKASHVAND A, Izadian A, Hajrasouliha A
     Advances in Ophthalmic Therapeutic Delivery: A Comprehensive Overview of Present and Future Directions.
     Surv Ophthalmol. 2024 Jul 8:S0039-6257(24)00076.
     PubMed     Abstract available
     
     
     
150. HASHEMI E, Looha MA, Mazaherinia H, Samadaeian N, et al
     Risk of stroke development following retinal vein occlusion: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 Jul 3:S0039-6257(24)00074.
     PubMed     Abstract available
     
     
     
151. SINCLAIR SH, Schwartz S
     Diabetic retinopathy: New concepts of screening, monitoring, and interventions.
     Surv Ophthalmol. 2024 Jul 2:S0039-6257(24)00077.
     PubMed     Abstract available
     
     
     
152. WU H, Jin K, Yip CC, Koh V, et al
     A systematic review of economic evaluation of artificial intelligence-based screening for eye diseases: From possibility to reality.
     Surv Ophthalmol. 2024;69:499-507.
     PubMed     Abstract available
     
     
     
153. BUNJO LJ, Bacchi S, Pietris J, Chan WO, et al
     Current management options for the treatment of refractory postoperative cystoid macular edema: A systematic review.
     Surv Ophthalmol. 2024;69:606-621.
     PubMed     Abstract available
     
     
     
154. LEIDY L, Dickinson A, Ramulu P, Ehrlich J, et al
     Clinical outcome measures in vision and eye care.
     Surv Ophthalmol. 2024;69:632-637.
     PubMed     Abstract available
     
     
     June 2024
155. HOSSEINI F, Asadi F, Rabiei R, Kiani F, et al
     Applications of artificial intelligence in diagnosis of uncommon cystoid macular edema using optical coherence tomography imaging: A systematic review.
     Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00073.
     PubMed     Abstract available
     
     
     
156. PARRAVANO M, Cennamo G, Di Antonio L, Grassi MO, et al
     Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers.
     Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00075.
     PubMed     Abstract available
     
     
     
157. DAUNGSUPAWONG H, Wiwanitkit V
     Generative artificial intelligence in ophthalmology: Correspondence.
     Surv Ophthalmol. 2024 Jun 17:S0039-6257(24)00071.
     PubMed    
     
     
     
158. FARAHAT Z, Zrira N, Souissi N, Bennani Y, et al
     Diabetic retinopathy screening through artificial intelligence algorithms: A systematic review.
     Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00051.
     PubMed     Abstract available
     
     
     
159. POSARELLI M, Passaro ML, Avolio FC, Costagliola C, et al
     The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment.
     Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00069.
     PubMed     Abstract available
     
     
     
160. WAISBERG E, Ong J, Masalkhi M, Lee AG, et al
     Future directions of generative artificial intelligence in ophthalmology and vision science.
     Surv Ophthalmol. 2024 Jun 14:S0039-6257(24)00072.
     PubMed    
     
     
     May 2024
161. BACHMEIER I, Armendariz BG, Yu S, Jager RJ, et al
     Corrigendum to "Fibrosis in neovascular age-related macular degeneration: a review of definitions based on clinical imaging" [Surv Ophthalmol 68 (2023) 835-848/5].
     Surv Ophthalmol. 2024 May 28:S0039-6257(23)00137.
     PubMed    
     
     
     
162. HERNANDEZ RF, Rodriguez JEM, Trecu MS, Tariq Bhatti M, et al
     Not everything is ischemic optic neuropathy.
     Surv Ophthalmol. 2024 May 23:S0039-6257(24)00054.
     PubMed     Abstract available
     
     
     
163. VEMPULURU VS, Maniar A, Bakal K, Kaliki S, et al
     Role of MYCN in Retinoblastoma: A Review of Current Literature.
     Surv Ophthalmol. 2024 May 23:S0039-6257(24)00055.
     PubMed     Abstract available
     
     
     
164. CHENG T, Gu X, Yang Z, Wang C, et al
     Clinical features of ocular damage in systemic lupus erythematosus and risk factors of hydroxychloroquine related complications.
     Surv Ophthalmol. 2024 May 21:S0039-6257(24)00052.
     PubMed     Abstract available
     
     
     
165. KNECHT KT, Chiriac G, Guan HD
     The potential impact of a vegetarian diet on glaucoma.
     Surv Ophthalmol. 2024 May 18:S0039-6257(24)00048.
     PubMed     Abstract available
     
     
     
166. WAISBERG E, Ong J, Kamran SA, Masalkhi M, et al
     Generative artificial intelligence in ophthalmology.
     Surv Ophthalmol. 2024 May 16:S0039-6257(24)00044.
     PubMed     Abstract available
     
     
     
167. FEKRAZAD S, Hassanzadeh G, Salehi MA, Mozafar M, et al
     Optical coherence tomography angiography measurements in systemic lupus erythematosus: A systematic review and meta-analysis.
     Surv Ophthalmol. 2024 May 12:S0039-6257(24)00047.
     PubMed     Abstract available
     
     
     
168. TRINCAO-MARQUES TM, Ayton LN, Hickey DG, Marques-Neves C, et al
     Gene and cell therapy for age-related macular degeneration: A review.
     Surv Ophthalmol. 2024 May 10:S0039-6257(24)00049.
     PubMed     Abstract available
     
     
     
169. NIAZI S, Doroodgar F, Nazari SH, Rahimi Y, et al
     Refractive surgical approaches to keratoconus: A systematic review and network meta-analysis.
     Surv Ophthalmol. 2024 May 4:S0039-6257(24)00045.
     PubMed     Abstract available
     
     
     
170. TAWFIK HA, Ali MJ
     A major review of punctal stenosis: Updated anatomy, epidemiology, etiology, and clinical presentation.
     Surv Ophthalmol. 2024;69:441-455.
     PubMed     Abstract available
     
     
     
171. HUANG RS, Mihalache A, Popovic MM, Cruz-Pimentel M, et al
     Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
     Surv Ophthalmol. 2024;69:456-464.
     PubMed     Abstract available
     
     
     
172. ROY R, Chattree S, Kala U, Majumdar B, et al
     Multicolor imaging: Current clinical applications.
     Surv Ophthalmol. 2024;69:378-402.
     PubMed     Abstract available
     
     
     
173. ARORA S, Zur D, Iovino C, Chhablani J, et al
     Peripapillary fluid: Obvious and not so obvious!
     Surv Ophthalmol. 2024;69:311-329.
     PubMed     Abstract available
     
     
     
174. PELLEGRINI F, Basciu M, Foroozan R
     Planet of the apex.
     Surv Ophthalmol. 2024;69:495-498.
     PubMed     Abstract available
     
     
     April 2024
175. VERA-DUARTE GR, Jimenez-Collado D, Kahuam-Lopez N, Ramirez-Miranda A, et al
     Neurotrophic keratopathy: General features and new therapies.
     Surv Ophthalmol. 2024 Apr 26:S0039-6257(24)00042.
     PubMed     Abstract available
     
     
     
176. LEE YM, Bahrami B, Selva D, Casson RJ, et al
     Scoping review of non-surgical treatment options for macular holes.
     Surv Ophthalmol. 2024 Apr 25:S0039-6257(24)00043.
     PubMed     Abstract available
     
     
     
177. KANG C, Lee MJ, Chomsky A, Oetting TA, et al
     Risk factors for complications in resident-performed cataract surgery: A systematic review.
     Surv Ophthalmol. 2024 Apr 20:S0039-6257(24)00032.
     PubMed     Abstract available
     
     
     
178. SALEHI MA, Frounchi N, Zakavi SS, Mohammadi S, et al
     Retinal and choroidal changes after anti-VEGF therapy in Neovascular-AMD Patients: A Systematic Review and Meta-Analysis of SD-OCT studies.
     Surv Ophthalmol. 2024 Apr 17:S0039-6257(24)00033.
     PubMed     Abstract available
     
     
     
179. KROLO I, Behaegel J, Termote K, de Bruyn B, et al
     The role of topical insulin on ocular surface restoration: A review.
     Surv Ophthalmol. 2024 Apr 10:S0039-6257(24)00031.
     PubMed     Abstract available
     
     
     March 2024
180. ARDA H, Maier M, Schultheiss M, Haritoglou C, et al
     Advances in management strategies for large and persistent macular hole: an update.
     Surv Ophthalmol. 2024 Mar 27:S0039-6257(24)00030.
     PubMed     Abstract available
     
     
     
181. NOURI H, Abtahi SH, Mazloumi M, Samadikhadem S, et al
     Optical coherence tomography angiography in diabetic retinopathy: A major review.
     Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00021.
     PubMed     Abstract available
     
     
     
182. BRESSLER NM, Kaiser PK, Do DV, Nguyen QD, et al
     Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review.
     Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00029.
     PubMed     Abstract available
     
     
     
183. SCHEFFER M, Menting J, Boeije H, van Nispen R, et al
     Understanding healthcare communication in age-related macular degeneration care: A mixed-methods review of patients' perspectives.
     Surv Ophthalmol. 2024 Mar 16:S0039-6257(24)00018.
     PubMed     Abstract available
     
     
     
184. SABATINO F, Banerjee P, K Muqit MM
     Clinical therapeutics for proliferative vitreoretinopathy in retinal detachment.
     Surv Ophthalmol. 2024 Mar 15:S0039-6257(24)00024.
     PubMed     Abstract available
     
     
     
185. ANG T, Chaggar V, Tong JY, Selva D, et al
     Medication-associated orbital inflammation: A systematic review.
     Surv Ophthalmol. 2024 Mar 13:S0039-6257(24)00020.
     PubMed     Abstract available
     
     
     
186. ORTIZ-SELLER A, Martorell P, Barranco H, Pascual-Camps I, et al
     Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis.
     Surv Ophthalmol. 2024 Mar 1:S0039-6257(24)00008.
     PubMed     Abstract available
     
     
     
187. OO HH, Mohan M, Song W, Rojas-Carabali W, et al
     Anterior chamber inflammation grading methods: A critical review.
     Surv Ophthalmol. 2024;69:253-264.
     PubMed     Abstract available
     
     
     
188. YESILTAS YS, Oakey Z, Wrenn J, Yeaney G, et al
     Uveal melanoma in African Americans: Diagnostic challenges.
     Surv Ophthalmol. 2024;69:190-197.
     PubMed     Abstract available
     
     
     
189. ARNOLD RW
     Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
     Surv Ophthalmol. 2024;69:295.
     PubMed    
     
     
     
190. ROBBINS SL, Greenberg M, Juan I
     Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
     Surv Ophthalmol. 2024;69:S0039-625700087-5.
     PubMed    
     
     
     February 2024
191. JIANG F, Lei C, Chen Y, Zhou N, et al
     The complement system and diabetic retinopathy.
     Surv Ophthalmol. 2024 Feb 23:S0039-6257(24)00007.
     PubMed     Abstract available
     
     
     September 2023
192. PELLEGRINI F, Basciu M, Falardeau J
     Pole to pole.
     Surv Ophthalmol. 2023;68:1002-1005.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ophthalmology is free of charge.